Novartis Polandsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-10-31
Share capital
44 183 000,00 PLN
Activity description

Novartis Poland is part of a global healthcare company that works with patients, caregivers and healthcare professionals to improve and extend human life. The company supports knowledge exchange, education and therapy development, while pursuing environmental and social responsibility and building a diverse team serving more than 766 million patients worldwide.

Registered address
Marynarska 15, 02-674 Warszawa, Poland
Website
novartis.comWebsite active
Social media
Electronic delivery address
AE:PL-57849-90025-BVIHT-28

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 378.15mMedianUSD 874.89kAverageUSD 20.29m
Net profit
This companyUSD 11.86mMedianUSD 28.28kAverageUSD 815.91k
Operating costs
This companyUSD 358.81mMedianUSD 806.30kAverageUSD 19.08m
Assets
This companyUSD 248.32mMedianUSD 541.70kAverageUSD 10.94m

Industry

Bank accounts

Registered as a VAT taxpayer on 1993-07-05. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Real estate

TypeAmount
Buildings and premises
PLN 1.6M

MSiG notices

Publication dateEvent
Apr 22, 2025Merger registered

Public aid

No public aid cases recorded in the last 10 years.

Tenders

12 tenders recorded as contractor, with a total value of $84,644,222.

SubjectAmount
Dostawa produktów leczniczych Programy lekowe w ramach terapii CAR-T
$23.6M
„Dostawa leków, preparatów farmaceutycznych, leków onkologicznych, wyrobów medycznych, materiałów opatrunkowych, materiałów szewnych, kontrastów i innych.”
$4.2M
Produkt leczniczy - Tisagenlecleucelum
$3.4M

Public sector contracts

Novartis Poland is the contractor in 5 public sector contracts, worth PLN 2.54m in total. They were signed with 4 public buyers.

Public buyerValue
Uniwersyteckie Centrum KlinicznePLN 2,544,000
Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu MedycznegoPLN 27.00
Centrum Onkologii Im. Prof. Franciszka Łukaszczyka w BydgoszczyPLN 3.00
Centrum Onkologii Im. Prof. Franciszka Łukaszczyka w BydgoszczyPLN 3.00
Uniwersytecki Szpital Kliniczny w PoznaniuPLN 3.00

Trademarks

Novartis Poland currently holds no active trademarks with the Polish Patent Office. 3 marks have expired or were not registered. The first mark was filed in 2009.

MarkProtected until
ZROZUM LEPIEJ SWOJĄ MIGRENĘ Z EXCEDRIN MIGRASTOP–
DiabetoNews(word)–
KOJĄCY DOTYK(word)–

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Jolanta Chlebicka Dominiak – Attorney-in-fact (sole)
Carlos Eid – Management Board Member
Emiliano Zavagli – Management Board Member
Yu Tian – President of the Management Board

Manner of representation

The following are authorized to submit declarations of will within the scope of rights and obligations and to sign documents on behalf of the company: each member of the management board independently or an individual commercial proxy independently.

Ownership

OwnerSharesShare valueStake
Novartis Pharma Ag
44,183$11,934,900.05100%

Beneficial owners

Person

Competitors

Name
Roche Polskasp. z o.o.
Bayersp. z o.o.
Bausch Health Polandsp. z o.o.
Sanofisp. z o.o.
USP Zdrowiesp. z o.o.
MSD Polska Dystrybucjasp. z o.o.
A.P.N. PromiseS.A.
Pfizer Trading Polskasp. z o.o.
NovoS.A.
Servier Polska Servicessp. z o.o.

Change history

DateEvent
2010-12-20Address change
2004-02-16Share capital change
2001-10-31Entered in the register

FAQ

Last updated: 2026-10-02